from the APF:
"We are still awaiting news if there will be follow-up trials for Afamelanotide for EPP."
They're referring to the U.S.
I have to say I've been a little concerned. Not about whether Phase II in the US went well - but rather whether or not they will be able start Phase III in the U.S. in time with the Phase II results still not reported yet.
Last year, we had to wait until very late March to get the green light from the FDA about Phase II.
apf udpate on us trial
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.29 |
Change
-0.430(2.92%) |
Mkt cap ! $722.1M | |||
| Open | High | Low | Value | Volume |
| $15.00 | $15.00 | $14.27 | $564.2K | 38.87K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 169 | $14.27 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.29 | 120 | 11 |
View Market Depth
| Last trade - 14.18pm 09/09/2024 (20 minute delay) ? |
| CUV (ASX) Chart |